degarelix
Showing 26 - 50 of 87
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Replication of PRONOUNCE Prostate Cancer Trial in Healthcare
Active, not recruiting
- Prostate Cancer
- Degarelix
- Leuprolide
-
Boston, MassachusettsBrigham and Women's Hospital
May 18, 2021
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)
Recruiting
- Prostate Adenocarcinoma
- Leuprolide Acetate
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)
Terminated
- Prostatic Neoplasms
- Degarelix
-
London, Ontario, Canada
- +2 more
May 5, 2020
Prostate Cancer Trial in Abbottsford, Surrey, Vancouver (Degarelix)
Completed
- Prostate Cancer
- Degarelix
-
Abbottsford, British Columbia, Canada
- +2 more
Jan 23, 2020
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston
Withdrawn
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Apalutamide
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2021
Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event Trial in Petah Tikva (Degarelix, GnRH agonist)
Unknown status
- Hormone Sensitive Prostate Cancer
- +2 more
- Degarelix
- GnRH agonist
-
Petah Tikva, IsraelRabin Medical Center - Beilinson Hospital
Nov 27, 2019
Adenocarcinoma of Prostate Trial in France (Degarelix, Pelvic Radiotherapy)
Active, not recruiting
- Adenocarcinoma of Prostate
- Degarelix
- Pelvic Radiotherapy
-
Angers, France
- +38 more
May 11, 2022
Treatment of Prostate Cancer With Firmagon®
Completed
- Prostate Cancer
- Degarelix
-
Planegg, Bavaria, GermanyUCM GmbH
Apr 9, 2020
Prostate Cancer Trial in Cambridge (Olaparib, Degarelix)
Completed
- Prostate Cancer
- Olaparib
- Degarelix
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital, Cambridge University Hospitals Foundatio
Aug 28, 2019
Safety and Efficacy of Firmagon® (Degarelix) for Injection
Completed
- Prostate Cancer
- degarelix
-
Seoul, Korea, Republic ofGangnam Severance Hospital (there may be other sites in this cou
Jun 14, 2019
Hormone Naïve Prostate Cancer and Without Comorbidities Treated
Completed
- Advanced Prostate Cancer
- Degarelix
- LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)
-
Rottweil, GermanyInvestigational site (there may be other sites in this country)
Jul 1, 2019
Prostate Cancer Trial in Houston (Ipilimumab, Leuprolide, Goserelin)
Terminated
- Prostate Cancer
- Ipilimumab
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 16, 2019
Prostate Cancer Recurrent Trial in Canada (degarelix)
Terminated
- Prostate Cancer Recurrent
- degarelix
-
Vancouver, British Columbia, Canada
- +14 more
Sep 19, 2019
Prostate Cancer Trial in Worldwide (Degarelix, approved GnRH agonist, Radiotherapy)
Recruiting
- Prostate Cancer
- Degarelix
- +2 more
-
Brussels, Belgium
- +38 more
Sep 3, 2021
Describing Global Patient Care and Follow-up of Prostate Cancer
Completed
- Prostate Cancer
- Degarelix
-
Orléans, FranceHopital de la Source (there may be multiple sites in this countr
Feb 25, 2019
Normal Healthy Volunteers Trial in Rochester (Degarelix, Testosterone, Anastrozole)
Completed
- Normal Healthy Volunteers
- Degarelix
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 5, 2019
Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)
Completed
- Prostate Adenocarcinoma
- +4 more
- Degarelix
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2018
Prostatic Tumors Trial in Japan (degarelix)
Completed
- Prostatic Neoplasms
- degarelix
-
Chubu, Japan
- +7 more
May 31, 2019
Prostate Cancer Trial in Houston (Degarelix, Doxorubicin, Ketoconazole)
Terminated
- Prostate Cancer
- Degarelix
- +4 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Nov 2, 2018
Prostatic Tumors Trial in Houston (Doxorubicin, Ketoconazole, Docetaxel)
Terminated
- Prostatic Neoplasms
- Doxorubicin
- +4 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Nov 2, 2018
Real-life Data of Cardiovascular Events Occuring During
Completed
- Advanced Hormone Sensitive Prostate Cancer
- degarelix
-
Gouda, NetherlandsGroene Hart Ziekenhuis (there may be other sites in this country
Nov 23, 2017